BLTE
Belite Bio, Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
No N-PORT holders.
No thesis.
Belite Bio, Inc
154.60
Expected move
No implied move.
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Darwin Global ManagementDarwin Global | $456.6M | 31.67% | +0.65% | |
| 2 | Paradigm Biocapital AdvisorsParadigm Biocapital | $189.8M | 13.17% | +10.59% | |
| 3 | RTW InvestmentsRTW | $110.2M | 7.64% | 0.00% | |
| 4 | Millennium ManagementMillennium | $76.2M | 5.28% | −13.25% | |
| 5 | Maverick CapitalMaverick Capital | $61.0M | 4.23% | new | |
| 6 | Eventide Asset ManagementEventide | $60.2M | 4.17% | +9.28% | |
| 7 | Deerfield ManagementDeerfield | $55.0M | 3.82% | +17.49% | |
| 8 | Holocene AdvisorsHolocene | $38.7M | 2.68% | −49.23% | |
| 9 | Logos Global ManagementLogos Global | $38.5M | 2.67% | new | |
| 10 | Morgan StanleyMorgan Stanley | $36.2M | 2.51% | +16.71% | |
| 11 | UBS GroupUBS | $34.6M | 2.40% | −70.72% | |
| 12 | Citadel AdvisorsCitadel | $28.7M | 1.99% | +9171.31% | |
| 13 | Goldman Sachs GroupGoldman Sachs | $25.6M | 1.78% | +57.51% | |
| 14 | Affinity Asset AdvisorsAffinity Asset | $25.4M | 1.76% | +153.85% | |
| 15 | MPM Oncology Impact ManagementMPM Oncology Impact | $21.1M | 1.47% | +55.84% | |
| 16 | Bank of AmericaBank of America | $19.2M | 1.33% | +3202.89% | |
| 17 | Patient Square CapitalPatient Square Capital | $16.9M | 1.18% | −5.73% | |
| 18 | Duquesne Family OfficeDuquesne Family Office | $16.3M | 1.13% | 0.00% | |
| 19 | T. Rowe Price AssociatesT. Rowe Price | $16.3M | 1.13% | −62.44% | |
| 20 | Jane Street GroupJane Street | $10.1M | 0.70% | +438.38% | |
| 21 | BNP Paribas ArbitrageBNP Paribas Arbitrage | $8.8M | 0.61% | +75.63% | |
| 22 | Renaissance TechnologiesRenaissance Technologies | $8.6M | 0.60% | +7.24% | |
| 23 | Point72 Asset ManagementPoint72 | $7.9M | 0.55% | new | |
| 24 | Soleus Capital ManagementSoleus | $7.8M | 0.54% | new | |
| 25 | Trexquant InvestmentTrexquant Investment | $7.6M | 0.53% | +228.53% |
80 managers report $1.4B of Belite Bio on form 13F for the quarter ended Jun 30 '26. 11 of them hold 80% of it; Darwin Global is largest at 31.67%.